ArticleCancers2025

Inhibition of Galectin-1 and Androgen Receptor Axis Enhances Enzalutamide Treatment in Enzalutamide Resistant Prostate Cancer.

Hsiao-Chi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.